Skip to main content

Table 4 Multivariate analysis of prognostic factors

From: Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram

Prognostic factors

HR

95% CI

P value

Gender (male/female)

1.297

0.954–1.762

0.097

KPS (<80/≥80)

2.087

1.539–2.831

<0.001

Metachronous/Synchronous

0.685

0.489–0.961

0.028

ECM (N/Y)

0.749

0.054–1.012

0.060

Histology (non-adenocarcinoma/adenocarcinoma)

1.303

1.114–1.524

0.001

  1. MST median survival time, KPS Karnofsky performance status, ECM extracranial metastases